HRT FINANCIAL LP

Position in MRVI — Maravai Lifesciences Holdings, Inc.

CIK 1475597 NEW YORK, NY

Position in MRVI

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$215,880

-$979,830 QoQ

Shares Held

76,283

-79.3% QoQ

Ownership

0.030%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HRT FINANCIAL LP holds $416,725,359 across 197 Biotechnology names. MRVI ranks #107 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	128,633	$42,560,800
2	IBRX	ImmunityBio, Inc.	3,925,446	$30,108,170
3	EXEL	Exelixis, Inc.	460,585	$19,754,490
4	IONS	Ionis Pharmaceuticals Inc	252,250	$18,941,452
5	MRNA	Moderna, Inc.	368,421	$18,715,786
6	ARGX	Argenx SE	18,754	$13,695,108
7	RARE	Ultragenyx Pharmaceutical Inc.	613,229	$12,847,147
8	IOVA	Iovance Biotherapeutics, Inc.	3,486,299	$12,236,909

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$215,880	76,283	-79.3%	Shares	Defined	2026-05-14
2025-12-31	$1,195,710	367,911	+1011.0%	Shares	Defined	2026-02-12
2025-03-31	$73,186	33,116	-78.5%	Shares	Defined	2025-05-15
2024-12-31	$837,528	153,675	-61.4%	Shares	Defined	2025-02-14
2024-03-31	$3,450,200	397,947	+254.1%	Shares	Defined	2024-05-13
2023-12-31	$736,128	112,386	+16.6%	Shares	Defined	2024-02-09
2023-06-30	$1,197,816	96,365	+443.0%	Shares	Defined	2023-08-11
2023-03-31	$248,621	17,746	+93.4%	Shares	Defined	2023-05-12
2022-06-30	$260,690	9,176	-78.4%	Shares	Defined	2022-08-12
2022-03-31	$1,500,632	42,547	-86.1%	Shares	Defined	2022-05-16
2020-12-31	$8,566,329	305,395	—	Shares	Defined	2021-02-16
No filing history on record for this holder in this stock.